Department profile
Goodmans LLP

Intellectual Property

Global Guide 2026 : Canada


Goodmans LLP

Rankings

About

Provided by Goodmans LLP

Goodmans Intellectual Property Litigation lawyers are always at the forefront of industry-altering patent issues arising before the Supreme Court of Canada and the Federal Court of Appeal, shaping the law through original thinking and thoughtful legal solutions imported from other jurisdictions. Whether asserting intellectual property or defending against IP claims, the Goodmans Intellectual Property Litigation Group has unparalleled experience litigating complex and high-stakes IP litigation. Our Goodmans IP litigation bench is deep, with industry-recognized lawyers and leaders of the future working alongside several in-house PhD-level scientists.

Industry leaders repeatedly turn to Goodmans when the need arises to assert their intellectual property rights, whether it be patents, trademarks or copyright or to defend against claims of patent, trademark or copyright infringement. Clients from a multitude of industries choose Goodmans when they want client-focused, tailor-made strategies for building and managing IP portfolios and designing around the IP of their competitors.

The Group has received numerous recognitions, including Canada Firm of the Year - Patent Disputes and Impact Case of the Year at the Managing IP Awards Americas 2024, Intellectual Property Firm of the Year at the Benchmark Canada Awards 2024, Leading IP Law Firm - IP Patents at the Lexology Awards: North America 2024, and Impact Case of the Year at the LMG Life Sciences Americas Awards 2024 and 2025.

Chambers Review

Provided by Chambers

Intellectual Property - Canada


What the Team is Known For
Goodmans houses a well-regarded Toronto-based intellectual property department with notable strength in handling complex litigation. Renowned for its leading expertise in the pharmaceutical sector, the law firm covers both disputes and non-contentious issues. The team also offers experience in transactional, licensing and portfolio management files, often working for well-known domestic and international brands. The group enjoys a strong reputation for its assured handling of patent litigation matters, particularly for longstanding client Apotex.

Work Highlights

Provided by Chambers

  • Goodmans represented Pharmascience in a patent infringement action brought by Janssen concerning its intention to market low-cost subsequent entry versions of Janssen’s drug to treat multiple sclerosis, INVEGA SUSTENNA.

Strengths

Provided by Chambers

  • Goodmans are excellent litigators.

    Intellectual Property respondentGlobal
  • The firm has a very deep bench and strong technical depth.

    Intellectual Property respondentGlobal
  • Goodmans has been nothing but world class to deal with.

    Intellectual Property respondentGlobal
  • The team at Goodmans is very prepared, responsive and knowledgeable.

    Intellectual Property respondentGlobal

Notable Practitioners

Provided by Chambers

  • Star IndividualsAndrew Brodkin
    Star IndividualsAndrew Brodkin

    Andrew Brodkin

    Andrew Brodkin is a leading intellectual property lawyer with considerable experience litigating complex pharmaceutical patent disputes. He has also represented major manufacturing, oil and gas, and technology clients in both patent and trade mark litigation.

    • Andrew Brodkin is very knowledgeable and very commercial.

      Intellectual Property respondentGlobal
    • Andrew is smart, strategic and lovely to work with.

      Intellectual Property respondentGlobal
    • Andrew Brodkin is an excellent advocate.

      Intellectual Property respondentGlobal
    • Andrew is a very calming influence, he is very practical and really sets the strategic narrative and vision.

      Intellectual Property respondentGlobal
  • Star IndividualsHarry Radomski
    Star IndividualsHarry Radomski

    Harry Radomski

    Legendary litigator Harry Radomski continues to be recognised as an eminent intellectual property expert, particularly with issues concerning pharmaceutical and media patent litigation.

    • Harry Radomski is a highly intelligent individual.

      Intellectual Property respondentGlobal
    • He is a leader in the industry.

      Intellectual Property respondentGlobal
  • Band 2Jordan D. Scopa
    Band 2Jordan D. Scopa

    Jordan D. Scopa

    Jordan Scopa continues to impress market observers on the basis of his prominent role in major pharmaceutical patent litigation files, particularly for clients on the generic side of the industry.
    • Jordan Scopa is hard working, brilliant, and strategic. As a result, his legal work packs a punch.

      Intellectual Property respondentGlobal
    • Jordan is a phenomenal litigator and a real force to be reckoned with, as well as a delight to work alongside.

      Intellectual Property respondentGlobal
    • Jordan Scopa is a strong strategic thinker.

      Intellectual Property respondentGlobal
  • Band 3Amalia Berg
    Band 3Amalia Berg

    Amalia Berg

    Amalia Berg assists clients with a host of trade mark issues, including clearance, prosecution and portfolio management. She has been retained by major brands across a range of industries including consumer products, technology and media.

    • Amalia Berg is a really strong lawyer.

      Intellectual Property respondentGlobal
  • Band 3Ben Hackett
    Band 3Ben Hackett

    Ben Hackett

    Ben Hackett holds a solid reputation as an IP litigator and has played an important role in several high-profile patent litigation cases, particularly in the pharmaceutical sector.
  • Band 5Jenene Roberts
    Band 5Jenene Roberts

    Jenene Roberts

    Jenene Roberts is an adept lawyer at assisting with patent infringement litigation. She frequently represents clients in the pharmaceutical sector.

    • Jenene is whip smart.

      Intellectual Property respondentGlobal

Ranked Individuals at Goodmans LLP (6)

Canada

Members

Provided by Goodmans LLP

What success is built on

Chambers is the leading data and intelligence partner for the legal sector.

Explore thought leadership